Shuhao ZhuCo Founder & Chief Scientific Officer at Guardian Therapeutics
Shuhao Zhu, PhD, has more than 20 years of industry experience in Discovery sciences in multiple therapeutic areas including Oncology, Autoimmune, Infectious Diseases, and Cardiovascular. He has been working to advance aptamer technology since 2005. In 2013, Shuhao co-founded Band Therapeutic based upon the discovery of BT200 and was responsible for the preclinical development of BT200. Band Therapeutics was acquired by Guardian Therapeutics in 2018 and he has since been the CSO of Guardian.